Institute of Development, Aging and Cancer, Tohoku University
1-1,Seiryo-machi,Aoba-ku,Sendai, 980-8575, Japan
NCT Number: NCT00877422
Pneumonia is the fourth leading cause of death and frequently occurs in institutionalized elderly people in Japan. Recently, several clinical and experimental studies have reported the importance of vitamin D in the regulation of immune functions and its deficiency is associated with susceptibility to some infections. In the present study, the investigators hypothesize that deficiency of serum vitamin D is associated with development of pneumonia, and supplementation of vitamin D may lower the incidence of pneumonia and prolong survival in institutionalized elderly subjects.
Looking for future studies?
Notify Me65 year and older
All sexes
Interventional
Not applicable
1-1,Seiryo-machi,Aoba-ku,Sendai, 980-8575, Japan
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Group A and Group C are followed without drugs and Group B is followed with vitamin D3.
Time frame: one year
Time frame: one year
Tohoku University
Other
Vitamin D Supplementation Prevents Pneumonia in Institutionalized Elderly Subjects
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04779242
Bacterial Infections, Bacterial Infections and Mycoses
Gabrovo, Bulgaria
View Trial DetailsNCT05417997
Bacterial Infections, Bacterial Infections and Mycoses
Kayseri, Turkey (Türkiye)
View Trial DetailsNCT03158727
Bacterial Infections, Bacterial Infections and Mycoses
Brussels, Brussels Capital, Belgium
View Trial DetailsNCT02493764
Bacterial Infections, Bacterial Infections and Mycoses
View Trial Details